MedTrace Logo

Pilot Compassionate Use Study of Thioctic Acid Treatment in Mitochondrial Myopathy

NCT00004770 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2005-06-24

No results posted yet for this study

Summary

OBJECTIVES:

I. Assess the efficacy of thioctic acid in treating a single patient with mitochondrial myopathy.

Conditions

  • Mitochondrial Myopathy

Interventions

DRUG

thioctic acid

Sponsors & Collaborators

  • University of Rochester

    collaborator OTHER

  • National Center for Research Resources (NCRR)

    lead NIH

Principal Investigators

  • Robert Griggs · University of Rochester

Study Design

Purpose
TREATMENT

Eligibility

Min Age
0 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1995-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00004770 on ClinicalTrials.gov